Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06411730
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-04-29
Brief Title:
A Study to Evaluate the Safety Tolerability and Drug Levels of Orally Administered BMS-986368 in Healthy Participants Healthy Elderly Participants and Healthy Participants of Japanese Ethnicity
Sponsor:
Celgene
Organization:
Celgene
Study Overview
Official Title:
A Phase 1 Randomized Double-blind Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Orally Administered BMS-986368 in Healthy Participants Healthy Elderly Participants and Healthy Participants of Japanese Ethnicity
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety tolerability and drug levels of orally administered BMS-986368 in healthy participants healthy elderly participants and healthy participants of japanese ethnicity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None